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Abstract
Current literature suggests that therapeutic misconception 
– a belief  by participants in a clinical trial that they are in fact 
simply being given clinical care – is common, especially among 
illiterate populations in developing countries.     Therapeutic 
misconception reflects problems in informed consent, as 
people agree to participate in clinical trials without being 
aware that the trial procedures and test products may not in 
fact benefit them.   
In this study of  Malawian adults who had participated in 
research projects of  various kinds during the preceding 
years, we found that the majority participated in research for 
the sake of  obtaining better quality treatment made available 
through the clinical trials as ancillary care.  Their consent to 
participate was not due to a belief  that the actual procedures 
of  the trial would directly benefit their health.   Respondents 
indicated that, government hospitals being crowded and 
commonly lacking drugs, they agreed to take part in research 
projects in the hope of  obtaining access to ancillary care 
provided by clinical trials.  
We conclude that in this environment, possibly owing to 
inadequacy of  routine health services, people make rational 
decisions to participate in research.  We question whether 
the term ‘therapeutic misconception’ accurately describes 
participants’ motivation under conditions of  limited 
resources. We also discuss the relevance of  these findings 
for understanding undue inducement in clinical trials. 
Introduction
Health research presents several unique ethical challenges 
in developing countries such as Malawi.  One of  the major 
ethical challenges that has been identified in studies conducted 
elsewhere is that of  research participants confusing medical 
research with routine medical care.  This challenge is referred 
to as a therapeutic misconception and is defined as a mistaken belief  
by trial participants that they are participating in research 
only for the sake of  being treated and not for the sake of  
generating or obtaining new information.  Appelbaum, Roth 
and Lidz first described “therapeutic misconception” in 1982. 
1 Since then, several studies have been conducted in order to 
investigate its existence and prevalence among clinical trial 
participants.  Some studies have sought to understand why 
it exists while others have sought to understand the role of  
investigators in its genesis. 2,3    Other related studies have 
sought to establish the understanding of  people who agree 
to participate in trials. To date, several authors have reported 
the difficulties that researchers face in describing the concepts 
of  research, randomization, placebo use and double blinding 
to trial participants. 4-10    
A therapeutic misconception occurs when a research subject 
transfers to the research setting the assumption that the 
physician always acts only in the best interests of  the patient. 
11  In research, there are procedures such as randomisation, 
placebo use and double blinding that challenge this assumption. 
These three major scientific procedures that separate clinical 
trials from routine health care pose challenges to one of  the 
principles of  ethics, namely beneficence – the obligation 
to do good.  According to this principle, the researcher is 
obliged to act in a way that benefits the wellbeing of  the 
research participant. The researcher is bound to maximize 
the chances of  a successful outcome.12   As a result of  a 
therapeutic misconception, research participants do not 
consider that they are going to be randomized to various 
groups, that there is a chance that they may receive a placebo, 
that a placebo does not contain the active ingredient, that the 
purpose of  the research is to test the product or intervention 
or that even the researchers or research staff  do not know 
whether they are giving individual participants the placebo 
or the active product or intervention.  For the investigator 
whose research involves patient care, ethical requirements 
governing the provision of  that care must, of  course, still 
prevail.  But the investigator has additional obligations to 
ensure that the study or trial is soundly accomplished.
According to Appelbaum, on average 70% of  trial participants 
in clinical research suffer from a therapeutic misconception. 13 
Some papers have suggested that therapeutic misconceptions 
are particularly prevalent among research participants in 
African populations that are characterized by low literacy 
levels.14,15  
Miller and Brody note that the two activities, medical 
research and treatment are fundamentally different and 
require different ethical approaches. In clinical care, the 
ultimate goal is to provide therapy to the individual.16 Thus 
any new knowledge gained is incidental to the main aim of  
the activity.  By contrast, the goal of  clinical research is to 
generate new knowledge that can help future patients.  Failure 
to distinguish the consequences of  research participation 
from receiving ordinary treatment may seriously undermine 
the informed consent of  research subjects.  Brody observes 
that a therapeutic misconception is a major practical 
problem in medical research even in developed countries 
and suggests that researchers and bioethicists have to find 
some ways of  eliminating it.17   Brody considers that the 
therapeutic misconception results primarily from an overlap 
between the role of  the attending physician and the role of  
the investigator in a research trial.  This overlap is greatest 
when the same physician occupies both roles with respect to 
a particular patient-subject.  With therapeutic misconception, 
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participants enrol in research without being aware of  the 
personal implications of  their participation.  
In this paper we report findings relevant to therapeutic 
misconception from the first qualitative phase of  a three-
year study of  clinical research taking place in Blantyre, 
Malawi.   The purpose of  the overall three-year study is to 
understand participants’ perceptions, understanding and 
attitudes towards health research.  The work presented in this 
study is from the first phase, aimed at gathering information 
on concepts and terminology in preparation for subsequent 
phases:  Phase 2 will be informed by Phase 1, but will be 
quantitative and will focus on participants of  selected clinical 
studies.  
Study setting
The study was carried out by a team from the Center for 
Bioethics in Eastern and Southern Africa (CEBESA) within 
the Department of  Community Health at the College of  
Medicine, University of  Malawi. The College of  Medicine 
in Blantyre is associated with many research programmemes, 
some in collaboration with the Malawi-Liverpool-Wellcome 
Trust Clinical Research Programmeme, the Johns Hopkins 
University Research Centre, the University of  North Carolina 
Research Centre, the Gates Foundation supported Malaria 
Alert Center, and the University of  Michigan Blantyre 
Malaria Project.  This institutional base puts the team in a 
strong position to conduct research in ethics related to past 
and ongoing clinical research.  The qualitative study was 
conducted in three locations in Southern Malawi, namely the 
rural settings of  Madziabango and Mpemba Health Centre 
catchment areas located in Traditional Authority Somba in 
Blantyre District and the urban location of  Bangwe Township 
within Blantyre City.  These locations were selected for the 
qualitative study because several medical research projects 
had been and are still being conducted there.  Bangwe is a 
ward within Blantyre City with a recorded population of  
35,729 (8,761 households) according to the 1998 population 
census; 14% of  this was under 5 years and 39% under 15 
years old.  It is one of  the most densely populated wards of  
Blantyre City with more than 3,200 persons per sq. km.  The 
mean maximum educational level in households is 7-9 years 
which is above the national average of  5.6 years. 18  Bangwe 
ward has a government health centre, primary schools 
(private and government), Faith Based Organizations, and 
several Non Governmental Organizations.   At the time of  
this study, the following projects were either completed or 
were underway in the area:
• Since January 2003 University of  Malawi’s College of  
Medicine (COM) and Salvation Army, a faith based 
organization, have been carrying out a home based care 
and nutrition programme for people living with HIV/
AIDS. Every year, first year medical students conduct 
demographic surveys among the project clients in 
fulfilment of  their community health curriculum. 
• The Johns Hopkins Research Centre was running a 
study focused on the prevention of  mother to child 
transmission using Nevirapine. Participants are HIV 
positive mothers and their newborn infants. The study 
is ongoing.
• The Wellcome Trust funded the Azithromycin for 
Prevention of  Preterm Labour Study (APPLE), 
focusing on infections in pregnancy and premature 
deliveries was also going on in the area.
The rural communities of  Mpemba and Madziabango lie 
southwest of  Blantyre city, along a tarmac road (Blantyre-
Chikwawa road). Both are within Traditional Authority 
Somba, Blantyre District.  The population of  Mpemba and 
Madziabango are mainly subsistence farmers who grow 
chiefly maize, but who also cultivate cassava and vegetables 
and keep chickens.  Health institutions in TA Somba include 
Mpemba and Madziabango Health Centres.  At the time of  
this study, the following institutions had either completed 
studies or had studies underway:
• University of  North Carolina and College of  
Medicine’s Department of  Community Health had 
conducted a study focusing on prevention and control 
of  malaria in pregnancy. Participants were pregnant 
women who delivered at the health centres. The study 
was conducted between April 2002 and November 
2003. Follow up was being done at the time of  this 
study. 
• Population Services International, distributors of  
bed nets, is carrying out ongoing operational research 
since November 2004.  Three types of  bed nets were 
being compared and everyone can participate.
• The Gates Malaria Alert Centre is running a Drug 
Revolving Fund where village health committee 
members are being given malaria drugs to sell in the 
communities.
• An infant nutritional study [Mpemba only] is being 
carried out by an NGO called GOAL.
Study methods
Ethical approval was sought from the College of  Medicine 
Research and Ethics Committee (COMREC), additionally 
Blantyre District Health Officer (DHO) approved for the 
research to be conducted in Bangwe, Madziabango and 
Mpemba government health centers.  Through the Nursing 
Sister and Clinical Officers-in-Charge at each health centre, 
the local Health Surveillance Assistants (HSAs) were then 
approached to mobilize community members.  HSAs were 
called upon to assist in arranging the focus groups because of  
their familiarity with people living in the study communities. 
They approached both male and female community members 
and enquired whether they had participated in health research 
during the past three years or were currently participating in 
clinical studies. Those who confirmed and showed interest 
were invited to participate in the focus group discussions. 
After explaining the study, oral individual consent was 
obtained from each of  the respondents. The respondents 
were also asked to give their permission for audio-taping of  
the discussion. All the focus group discussions occurred in a 
private place in both settings. Each respondent was assigned 
a unique identification code and individual responses were 
represented by identification codes. 
Using this process, eighteen focus group discussions were 
held with 182 participants (76 rural; 106 urban) who were 
participating or had previously participated in health research. 
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Each focus group was composed of  6-12 people; of  whom 
13% were male and 87% female.  This unequal gender 
distribution was due to the fact that most of  the studies 
conducted in the three sites involved women and children. 
All focus group discussions were conducted in Chichewa and 
were recorded on audiotapes, which were then transcribed 
manually and translated from Chichewa into English by 
members of  the research team.   The number of  discussions 
was balanced between the rural and urban sites to allow for 
comparison; 9 focus groups were conducted in each setting. 
Table 1 shows the various FGDs that were held.   
Table 1:  Summary of Focus Groups 
Location No of Focus groups Male Female
Rural 9 21 84
Urban 9 2 75
Total 18 23 159
Results
Descriptions of research studies
Participants were asked to describe the studies that they have 
participated in, they described 14 studies .
Two observations are noticeable of  the programmes 
mentioned by the participants. Firstly, not all programmes 
mentioned by the research participants were clinical trials, 
nor were they health research projects of  any other kind, 
but were in fact standard health care interventions.   A few 
participants thought other routine health services, such as 
family planning, bilharzia screening, vaccinations against 
polio and measles, vitamin A administration, distribution 
of  chlorine to prevent cholera, distribution of  mectizan 
against black flies, TB screening, education and treatment, 
were health research in the local areas. That these health care 
provision programmes were thought to be research projects 
represents the inverse of  therapeutic misconception, which 
we might term ‘research misconception’.
Secondly, this problem makes it difficult to gather to what 
extent there is a therapeutic misconception among people 
who took part or were taking part in a research study.  We 
would expect a therapeutic misconception to manifest most 
in hospital based clinical trials, but participants were involved 
in a range of  health programmes and research activities, 
making the descriptions and understandings difficult to 
disentangle. Furthermore, the intervening period between 
their taking part in research and the time the FGDs may 
have led to recall bias. The question of  how pervasive the 
therapeutic misconception is cannot therefore be answered 
here and must be more thoroughly tackled in the second 
phase.  
What is research?
Given the responses reported and issues raised above, one 
of  the most important questions asked during the FGDs 
is the respondents’ understanding of  the term “research”. 
The majority of  the participants had an idea that research 
was about trying to find out about something.  Respondents 
from rural and urban areas came up with the same Chichewa 
expressions defining what research is.  All the terms suggest 
the idea of  “finding out” about something. Below are the 
recurring Chichewa expressions given by the respondents:
  • Kufufuza/kuwunguzawunguza/kufunafuna: to investigate
  • Kusakasaka: hunting for something.
  • Kalondolondo: to follow up on something.
  • Kusanthula/kuwunika: to illuminate.
  • Kalembera: a census.
Health research was seen by many peri-urban and rural 
respondents as investigating outbreaks of  diseases, 
establishing why they are occurring, and devising ways of  
preventing their spread:
Health research was also perceived to be diagnostic in nature: 
blood is drawn from participants to determine the cause of  a 
disease; the number of  cases is quantified and the population 
requiring assistance identified.
Health research was viewed by some as a way of  trying out 
the efficacy of  new drugs. This view was common among 
respondents.
The above quotes illustrate the complexity of  teasing out 
whether the investigations are part of  a systematic effort 
to produce new knowledge for the benefit of  the general 
population in the future (how we are defining research), or 
whether they were carried out as part of  health surveillance, 
health provision or public health initiatives.  
Why join studies?
In order to understand the role of  a therapeutic misconception 
in study participation, we interviewed participants who 
reported being aware that they were in studies to test the 
efficacy of  certain drugs or interventions.  We asked them 
why they decided to participate.  What clearly emerged 
was the fact that the desire to seek medical treatment 
overrode the primary intent of  health research.  Participants 
revealed that they often chose to participate in research so 
as to obtain better treatment.  Public hospitals are always 
overcrowded and short-staffed, and are characterized by 
long waiting hours, while private hospitals are very expensive. 
Respondents characterized normal health care in health 
centres as inadequate; medication is given without proper 
diagnosis, and the range of  medications available is often 
severely limited.
In health research, by contrast, participants perceive that 
treatment is prompt and is given after a proper diagnosis 
(screening of  blood, urine etc); hospitalized patients are 
“My understanding is that health research involves investigating 
a disease; to find out why the disease has come about, how to 
prevent it in case it has no cure, as well as how to find a cure 
for the disease.” (P5, FGD36, Participants - urban)
“According to me, my opinion is that when there is a wide 
spread disease among the people, whether it is malaria or 
HIV/AIDS, they (researchers) endeavor to investigate 
the cause of  the disease.” (P10, FGD33, Participants 
- urban)
“They wanted (researchers) to find out what he/she was 
suffering from and they were also trying a new drug for 
treatment” (P10, FGD37, Participants - urban)
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given good food and are sometimes discharged home in 
a project car. They are even followed up at a later stage in 
their homes.  Most of  the clinical trials associated with the 
College of  Medicine offer treatment free of  charge even for 
other problems not related to the study (‘ancillary care’), and 
people do not have to wait for hours since clinical trials are 
often adequately staffed.  
The views of  this participant embody this perception:
Differences between health research and routine health care:
Given the overlapping descriptions of  health research and 
routine health care, we also asked participants to describe 
the key differences between the two.  Many respondents 
cited quality of  care as a major distinguishing factor between 
health research and health care. Thus in health research, 
treatment and care is considered better than in normal health 
care. When hospitalized, they even provide good food:
In health research, investigators even make follow ups at 
your home:
The majority of  participants perceived the care that was 
offered through research projects as adequate and correct i.e. 
it is based on thorough diagnosis, unlike that which is offered 
through routine care which is mainly based on oral history 
only.  Thus, diagnosis was perceived not to be thorough in 
‘normal’ treatment.
An additional commonly cited difference was that in health 
research, people can take part even if  they are not sick which 
is not the case with health care: 
 
 
This comment is rather different from the previous ones. 
One possibility is that research is sometimes considered to 
be a form of  aid, or that it is linked to special health provision 
where illnesses are handled preventatively.  
Discussion
From the recorded comments of  the respondents in 
this study, it was evident that the majority had chosen to 
participate in a research project as a way of  accessing better 
quality health care, while knowing that the primary purpose 
of  the project was a research investigation.   In a situation 
of  poor service delivery as is the case in Malawi, research 
programmes commonly offer access to health care that is 
quicker, more comprehensive and more personal than is 
available in national medical facilities. Some respondents 
described visits to the hospital during which they spent 
several hours in the queue only to be told that there were no 
drugs for their problem.  
The findings lead us to ask the question: is it reasonable, 
ethically justifiable, and acceptable to offer, as a benefit of  
participation in a research project, better quality general 
health care than is available through the local health services? 
Or does such research in limited resource settings carry with 
it an undue inducement?   We are of  the opinion that if  
people make an autonomous decision to join health research, 
then permitting them to join with the principal motivation 
of  improving their health care is not unethical.   
The issue of  undue inducement becomes important only 
if  one does not consider the risks of  participation.  In 
most cases, the decision to participate in research was out 
of  perceived self-interest, with the main reason that of  
promoting health rather than the pursuit of  other material 
benefits.  In a scenario where the national health delivery 
system is overburdened and fails to adequately respond 
to individuals’ health needs, individuals will take the best 
available option, which may be to enrol in a research study. 
We view this decision as a rational one, because it is made 
after considering the advantages as well as the costs of  
deciding not to join the study on offer.  Of  concern though, 
is the fact that the participants place more importance on the 
benefits associated with participation.  It is not clear whether 
participants considered the risks associated with participation 
such as possible side reactions or bodily injury.  It is possible 
that research team members may play an important role in 
contributing towards the failure to consider risks, by placing 
more emphasis on benefits at the expense of  risks.
In the context of  the present inquiry, the overcrowded 
government hospitals and the expensive private hospitals 
are perhaps more correctly identified as constituting 
coercive circumstances than the research programmes.   In 
limited resource settings such as those prevailing in Malawi, 
research plays an important role that has not yet been fully 
acknowledged.  Research complements the national delivery 
systems which are overburdened.  By complementing local 
delivery systems, research is indirectly contributing – albeit in 
relatively small pockets - to the redistribution of  resources to 
poor communities.    At the same time the potential harmful 
impact of  the research on the routine health services should 
be assessed and mitigated so that others in the community 
do not suffer as a consequence of  the research.
Therapeutic misconception in Malawi 
How prevalent and how important is therapeutic 
misconception in the communities we have studied?   We 
believe that the term is context specific and that caution needs 
to be exercised in using it, particularly in resource limited 
“…when you are taking part in research, they treat you 
differently from those who are not taking part in research. 
For example, if  you are suffering from some illness and you 
explain to the doctor that you are a research participant, they 
try hard to give you all the care needed. But if  you are not a 
participant, they can just give you aspirin and you go”. (P5, 
FGD no.39) 
“When you take part in health research, the reception you 
are accorded is very warm and you are free to reveal all your 
worries according to your health problem. But when you go to 
government hospitals, once you name your major complaint, it 
ends there. There is no room for additional complaints.” (P5, 
FGD34, Participants - urban)
“In a health study, after giving the patient medication they 
even make follow ups at the home of  the patient to monitor 
her progress. When other patients receive normal care at the 
hospital that is the end of  it.” (P7, FGD17, - rural)
“You may go to the hospital tell them you are suffering from 
headache or fever. They just prescribe the medicine for you for 
fever. They do not screen you. While when you go to a health 
research, they screen you first to find out exactly what the 
problem is. Soon after diagnosis, you are given medicine.” (P5, 
FGD44, Participants - urban)
 “The difference is that we get medical treatment when we are 
sick while in research you are given all sorts of  assistance even 
if  you are not sick.” (P4, FGD4, urban). 
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settings.  A therapeutic misconception can be found in any 
situation in which it is difficult to tell the differences between 
routine care and clinical research.  In resource limited settings 
patients often judge the difference between research and 
routine care based on the quality of  care. In many cases this 
is a reflection of  the relatively large resources made available 
to  research programmes operating in resource constrained 
environments.  
For the term therapeutic misconception to fit a particular 
situation, there should be a mistaken belief  on the part of  
the patient that the research is aimed simply at treating their 
current disease.  A rational decision by someone to participate 
in a trial for the sake of  accessing better quality health care 
in general does not qualify for that label, except when he 
believes that the intervention itself  is designed to benefit him 
and does not understand the possibility of  being allocated 
to a control arm.  Therapeutic misconceptions, therefore, 
can be divided into two types: participants thinking that the 
research is normal (relatively good quality) health care, or 
thinking that it is research and assuming that the research 
intervention has individual benefit.  We believe that what we 
have observed in our study is less likely to be one of  these 
forms of  therapeutic misconception, and more likely to be 
the push and pull effects associated with limited resources. 
Our Phase 2 research will test this idea.
Do these findings indicate that the participants whose 
opinions we report have joined research projects because 
of  undue inducement?  In our view this is not the case. 
Our findings relate to people who are capable of  making 
decisions to promote their own health.  Research in African 
and other resource-limited countries plays an extra role that 
is yet to be fully acknowledged.  The appropriateness of  the 
term therapeutic misconception in a situation of  poor public 
health care has been questioned previously 19, and our study 
underlines this concern.        
Conclusion
Therapeutic misconception has been observed in many 
resource poor settings, as a result of  many factors including 
the difficulty experienced by researchers in explaining 
research concepts in such a way that participants adequately 
comprehend them4,5,7-10,13-15. In the communities we describe, 
the therapeutic misconception does not appear to have been 
a feature of  people’s participation in research.  Respondents 
were aware of  the investigative nature of  the studies in which 
they took part, and they participated in order to benefit from 
the superior general health care to which the research gave 
them access.  We argue, with others, that this is a reasonable 
and ethically acceptable motivation for taking part in 
research and does not constitute therapeutic misconception. 
This provision of  general and ancillary health services to 
research subjects does, however, require careful planning 
and monitoring to ensure that it does not lead participants, 
in their pursuit of  better clinical care, to ignore the potential 
risks of  being involved in research.  
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